AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its lead product is ABCL635, an non-hormonal medicine, which is in Phase 2 clinical trial ...
Q2 2026
Aug 6, 2026
Q1 2026
May 11, 2026
FY 2025
Feb 24, 2026
Q4 2025
Q3 2025
Nov 6, 2025
